SCHEMBL22692680

SCHEMBL22692680

CC(C)OCC1CC(OC(C)C)CN1C(=O)CC(C)(C)CC(C)(C)CC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26251780 0.93 — —
SCHEMBL19871862 0.89 — —
SCHEMBL24012450 0.85 — —
SCHEMBL20099270 0.83 — —
SCHEMBL16248511 0.82 DPP4 (0.32) —
SCHEMBL20099250 0.81 — —
SCHEMBL23790886 0.81 — —
SCHEMBL25466905 0.80 — —
SCHEMBL16692598 0.79 DPP4 (0.30) —
SCHEMBL17446584 0.79 DPP4 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844379-B2 Conjugated antisense compounds and their use IONIS PHARMACEUTICALS, INC. (US) 2020-11-24 — — US disclosed
Send feedback